Select Language
Free Registration

NoV(GII.13)VP1

NoV(GII.13)VP1 Product List

  • Product Category

    Antibody (1)

  • Product Status

    Launched (1)

  • Species

    Mouse (1)

  • Tag

    - (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
NO1-MY2228
Mouse
HEK293
Monoclonal Anti-Human NoV(GII.13)VP1 Antibody, Mouse IgG1 (2B10) (MALS verified)
Total: 1
  • 1

NoV(GII.13)VP1 Background

Noroviruses are icosahedral viruses in the family Caliciviridae, with a single-stranded, positive-sense RNA genome. Noroviruses are genetically diverse and can infect a wide variety of hosts. Norovirus is a leading cause of acute gastroenteritis (AGE) globally. They are divided into 10 genogroups (GI to GX) based on VP1 amino acid sequence. Each genogroup is subdivided into genotypes based on capsid amino acid sequence, with 49 genotypes currently described. Noroviruses can also be classified based on their RdRp (“polymerase”) sequence, with at least 60 P-types currently circulating.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SHR-9146HTI-1090; SHR-9146Phase 1 ClinicalSolid tumours; Neoplasms
Details
LPM-3480226LY-01013; LPM-3480226Phase 1 ClinicalLuye Pharma Group LtdSolid tumours
Details
DN-1406131DN-131; DN-1406131Phase 1 ClinicalJiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co LtdSolid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung
Details
  • Product List
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland